WeightWatchers CEO Sima Sistani, who pushed the company into embracing weight-loss drugs, is leaving the position after a two ...

WeightWatchers announced Friday that CEO Sima Sistani is no longer at the company, and independent board member Tara Comonte ...

About 40% of U.S. adults suffer from obesity, and the cost of covering GLP-1 agonists and related anti-obesity drugs can be ...

In this week’s Bloom Boost – health news you might have missed, Gayle Guyardo the host of the nationally syndicated health and wellness show Bloom  shares U.S. senators are ...

The company's shares have plummeted about 90 percent this year due to the rising popularity of GLP-1 drugs like Ozempic and ...

Obesity is high and holding steady in the U.S., but the proportion of those with severe obesity — especially women — has ...

Sima Sistani, who took up the CEO post at WW International two-and-a-half years ago, is out, according to the company.

Weight loss drugs are everywhere, and food manufacturers are paying attention. Nestlé just launched frozen meals tailored for people on weight loss drugs like Ozempic and Wegovy. We tested out their ...

Nestle launched frozen meals tailored for people on weight-loss drugs like Ozempic and Wegovy. We tried the teriyaki chicken ...

Sima Sistani helped push the company into the GLP-1 drug space with the $106 million acquisition of Sequence.

Jillian Michaels reiterated her stance on the dangers associated with the use of Ozempic, including any health issues that ...

International said Friday that CEO Sima Sistani is stepping down immediately. She will be replaced by Tara Comonte, a board ...